Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38
STK11 表达缺失是前列腺癌变的早期事件,可预测针对 MAPK/p38 的靶向治疗的治疗反应
期刊:Autophagy
影响因子:14.6
doi:10.1080/15548627.2015.1091910
Valentina Grossi, Giuseppe Lucarelli, Giovanna Forte, Alessia Peserico, Antonio Matrone, Aldo Germani, Monica Rutigliano, Alessandro Stella, Rosanna Bagnulo, Daria Loconte, Vanessa Galleggiante, Francesca Sanguedolce, Simona Cagiano, Pantaleo Bufo, Senia Trabucco, Eugenio Maiorano, Pasquale Ditonno,
信号转导
肿瘤
前列腺癌
IHC
MAPK/ERK
STK11